The Company:

This publicly held clinical-stage biotechnology company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Their lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN), an essential protein to the mitochondria of patients with Friedreich’s ataxia. Friedreich’s ataxia is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality.

The company has between 60 and 70 employees and has assembled an experienced management team, each of whom has over 20 years of pharmaceutical industry experience. The management team, employees, and consultants have significant expertise in discovery, nonclinical and clinical development, regulatory affairs, commercialization, and the development of manufacturing processes utilizing good manufacturing practices (GMPs).

The company’s strategy is to become a leader in the treatment of rare diseases by leveraging their technology platform and applying their team’s know-how and expertise to the development of CTI-1601 and other future pipeline programs. They are best characterized by entrepreneurial and scientific leadership and a participatory workforce committed to success.

Job Overview

The Director, Data Management is a key leader within the Biometrics function, responsible for defining and executing the company’s clinical data strategy across programs. This is a high-impact, hands-on leadership role suited for a dynamic biotech environment, where building, scaling, and transforming data management capabilities is critical to success.

This individual will lead end-to-end clinical data management activities, drive operational excellence, and ensure delivery of high-quality, inspection-ready data and documentation to support regulatory submissions, audits, and global health authority inspections.

Key Responsibilities

• Lead and scale the Data Management function, establishing vision, strategy, and execution plans aligned with company goals
• Oversee all aspects of clinical data management from study start-up through database lock, reporting, and archiving, ensuring continuous inspection readiness across programs
• Drive cross-functional collaboration with Clinical Development, Biostatistics, Regulatory, Quality, and external partners (e.g., CROs, vendors) to ensure seamless study execution and audit/inspection preparedness
• Establish and maintain data management standards, processes, and infrastructure, including SOPs, work instructions, and best practices aligned with inspection readiness expectations
• Provide oversight of key deliverables, including data management plans, edit check specifications, data validation processes, and database design (eCRFs), ensuring completeness, traceability, and auditability
• Ensure data quality, integrity, and timeliness through effective data review, cleaning strategies, and metrics-driven oversight, with a focus on producing inspection-ready datasets
• Lead and support inspection readiness activities, including preparation of documentation, participation in audits and regulatory inspections, and management of findings, CAPAs, and responses
• Identify and implement process improvements, innovative technologies, and scalable solutions to enhance efficiency, quality, and inspection preparedness
• Serve as a strategic partner to senior leadership, contributing to clinical development plans, regulatory strategy, and inspection readiness planning
• Foster a culture of accountability, collaboration, continuous improvement, and inspection readiness mindset within the team and across functions

Qualifications:

• Bachelor’s or Master’s degree (or equivalent experience) in a scientific or related field
• 10+ years of progressive experience in clinical data management within biotech/pharma, CROs, or a combination of both
• Demonstrated success supporting global clinical trials across multiple phases, including regulatory submissions, audits, and health authority inspections
• Direct experience leading or supporting inspection readiness activities, including audit preparation, documentation review, and CAPA management strongly preferred
• Experience building or transforming data management functions in a resource-constrained or fast-paced environment preferred
• Strong working knowledge of EDC systems, eCRF design, database development, data standards, and clinical data workflows
• Proven ability to lead vendors/CROs and manage complex timelines across multiple programs
• Deep understanding of GCP, ICH guidelines, and regulatory expectations for inspection readiness, data quality, and data integrity
• Strategic thinker with the ability to operate hands-on and adapt to evolving priorities
• Excellent communication and stakeholder management skills, with the ability to influence across functions and levels

Benefits:

Larimar Therapeutics offers all employees incentive stock options, a comprehensive benefits plan including 401K, and a flexible PTO policy.

We are committed to equal-employment principles, and we recognize the value of committed employees who feel they are being treated in an equitable and professional manner. We strive to find ways to attract, develop and retain the talent needed to meet business objectives, and to recruit and employ highly qualified individuals representing the diverse communities in which we live.

Employment policies and decisions on employment and promotion are based on merit, qualifications, performance, and business needs. The decisions and criteria governing the relationship with all candidates and employees are made in a non-discriminatory manner—without regard to age, race, color, national origin, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity or expression, religion, physical or mental disability, medical condition, legally protected genetic information, marital status, veteran status, military status, sexual orientation, or any other factor determined to be an unlawful basis for such decisions by federal, state, or local statutes.